Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 5, 1999, Pages 927-933

  Howarth, Peter H ^a   Stern, Martin A ^b   Roi, Larry ^c   Reynolds, Robert ^d   Bousquet, Jean ^e  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

^c Hoechst Marion Roussel   (United Kingdom)

^d SANOFI   (France)

^e HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Antihistamine; Cetirizine; Efficacy; Fexofenadine hydrochloride; Once daily; Safety; Seasonal allergic rhinitis; Total symptom score

Indexed keywords

CETIRIZINE; FEXOFENADINE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEASONAL VARIATION; TREATMENT PLANNING;

EID: 0032711088     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70070-9     Document Type: Article

References (22)

1. 1. Howarth PH. Cellular basis for allergic rhinitis. Allergy 1995;50(23 Suppl):6-10.
2. 2. Bousquet J, Vignola AM, Campbell AM, Michel FB. Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol 1996;110:207-18.
3. 3. Howarth PH, Wilson S, Lau L, Rajakulasingam K. The nasal mast cell and rhinitis [abstract]. Clin Exp Allergy 1991;21(2 Suppl):3-8.
4. 4. Simons FER, Simons KJ. Peripheral H1-blockade effect of fexofenadine. Ann Allergy Asthma Immunol 1997;79:530-2.
5. 5. Lippert C, Ling J, Brown P, Burmaster S, Eller M, Cheng L, et al. Mass balance and pharmacokinetics of fexofenadine HCl in healthy, male volunteers [abstract]. Pharm Res 1995;12:S390.
6. 6. Rampe D, Wible B, Brown AM, Dage RC. Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart. Mol Pharmacol 1993;44:1240-5.
7. 7. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;26:1532-6.
8. 8. Hey JA, del Prado M, Sherwood J, Kreutner W, Egan RW. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Arzneimittelforschung 1996;46:153-8.
9. 9. Bernstein D, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J. Efficacy and safety of fexofenadine for seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:443-8.
10. 10. Bronsky EA, Falliers CJ, Kaiser HB, Ahlbrandt R, Mason JM. Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies. Allergy Asthma Proc 1998;19:135-41.
11. 11. Pratt C, Mason J, Russell T, Ahlbrandt R. Effect of fexofenadine on corrected QT interval (QTc) [abstract]. Allergy 1997;52(37 Suppl):67.
12. 12. Craft TM. Torsade de pointes after astemizole overdose. BMJ 1986;292:660.
13. 13. Hey JA, del Prado M, Kreutner W, Egan RW. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes. Arzneimittelforschung 1996;46:159-63.
14. 14. Simons FE. H-1 receptor antagonists: does a dose-response relationship exist? Ann Allergy 1993;71:592-7.
15. 15. Tanner LA, Reilly M, Meltzer EO, Bradford JE, Mason J. Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J Managed Care 1999;5(Suppl):S235-47.
16. 16. Russell T, Stoltz M, Weir S. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers. Clin Pharmacol Ther 1998;64:612-21.
17. 17. Howarth PH, Wilson SJ, Brewster H. The influence of cetirizine on symptom generation and nasal eosinophilia in seasonal allergic rhinitis [abstract]. J Allergy Clin Immunol 1991;87:151.
18. 18. Kemp JP, Buckley CE, Gershwin ME, Buchman E, Cascio FL, Chretien JH, et al. Multi-center, double-blind, placebo controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Ann Allergy 1985;54:502-9.
19. 19. Clissold SP, Sorkin EM, Goa KL. Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989;37:42-57.
20. 20. Falliers CJ, Brandon ML, Buchman E, Connell JT, Dockhom R, Leese PT, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991;66:257-62.
21. 21. Weinberger M, Hendeles L. Formulations and dosage requirements for theophylline in the treatment of asthma. Curr Med Res Opin 1979;6:116-31.
22. 22. Wong L, Hendeles L, Weinberger M. Pharmacologic prophylaxis of allergic rhinitis: relative efficacy of hydroxyzine and chlorpheniramine. J Allergy Clin Immunol 1980;67:223-8.